Notice Concerning Revisions to Full-Year Financial Guidance for Fiscal Year Ending March 31, 2026 (FY2025)11/12TDnetPDF(157KB)
Terumo to acquire OrganOx Limited, a leading innovator in organ preservation devices, marking strategic entry into the organ transplantation-related8/25TDnetPDF(225KB)
Notice Concerning the Determination of Details of Issuance of Stock Options (Share Warrants) 8/4TDnetPDF(113KB)
Notice Concerning Completion of Disposal of Treasury Shares as Restricted Stock Remuneration8/4TDnetPDF(114KB)
Other Matters Subject to the Electronic Provision Measures 2025 Annual General Meeting5/29TDnetPDF(2MB)
Notice concerning differences in non-consolidated financial results between FY2023 and FY20245/14TDnetPDF(113KB)